Published in J Clin Invest on February 15, 1996
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int (2002) 3.23
The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab (2010) 2.26
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension (2003) 1.89
Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens (2012) 1.74
Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension. Hypertension (2014) 1.60
An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) (2008) 1.59
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol (2010) 1.51
Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens (2006) 1.46
Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension (2009) 1.45
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol (2006) 1.44
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest (1998) 1.34
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29
Reduced alpha-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock. J Physiol (2005) 1.22
A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther (2009) 1.19
Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens (2010) 1.18
A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci U S A (2002) 1.15
Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension (2012) 1.12
Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem (2008) 1.11
Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med (2013) 1.09
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch (2012) 0.99
Oxidative stress through activation of NAD(P)H oxidase in hypertensive mice with spontaneous intracranial hemorrhage. J Cereb Blood Flow Metab (2008) 0.95
Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res (2009) 0.91
Angiotensin-converting enzyme 2: central regulator for cardiovascular function. Curr Hypertens Rep (2010) 0.87
Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice. Pflugers Arch (2007) 0.87
Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension (2011) 0.87
A possible interaction between systemic and renal angiotensinogen in the control of blood pressure. Am J Hypertens (2013) 0.86
Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary. Int J Hypertens (2013) 0.85
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med (2011) 0.84
Angiotensin-converting enzyme 2: a new target for neurogenic hypertension. Exp Physiol (2009) 0.84
Cardiovascular responses to peripheral chemoreflex activation and comparison of different methods to evaluate baroreflex gain in conscious mice using telemetry. Am J Physiol Regul Integr Comp Physiol (2008) 0.84
Fibrotic Aortic Valve Stenosis in Hypercholesterolemic/Hypertensive Mice. Arterioscler Thromb Vasc Biol (2016) 0.80
Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease. Int Rev Thromb (2011) 0.80
HCaRG accelerates tubular repair after ischemic kidney injury. J Am Soc Nephrol (2011) 0.80
Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction. Neuroscience (2014) 0.79
The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Ageing Res Rev (2016) 0.77
ANG II-independent prorenin/(pro)renin receptor signaling pathways in the central nervous system. Am J Physiol Heart Circ Physiol (2015) 0.76
Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. Pflugers Arch (2014) 0.76
Structure and functions of angiotensinogen. Hypertens Res (2016) 0.75
Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats. Pflugers Arch (2013) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07
Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A (1995) 3.46
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature (1990) 2.54
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest (1990) 2.29
A mathematical model to assess changes in the baroreceptor reflex. Cardiology (1972) 2.23
Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci U S A (1994) 2.19
A DNA polymorphism, consistent with gene duplication, correlates with high renin levels in the mouse submaxillary gland. Cell (1982) 2.10
Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol (1994) 1.91
Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int (1981) 1.62
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J (1992) 1.48
Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension (1994) 1.45
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science (1989) 1.28
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nat Genet (1992) 1.25
Mechanisms by which angiotensin II affects the heart rate of the conscious sheep. Circ Res (1980) 1.24
Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem (1994) 1.22
Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A (1990) 1.18
Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci U S A (1992) 1.16
Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res (1981) 1.11
Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol (1984) 1.09
Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest (1990) 1.08
Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem (1994) 1.07
Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept (1993) 1.04
Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J Clin Invest (1993) 1.03
Selection for blood pressure levels in mice. Genetics (1974) 0.99
Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res (1992) 0.99
Renin-angiotensin system in genetically hypertensive mice. Jpn Circ J (1984) 0.95
Kallikrein-kinin and renin-angiotensin systems in rat renal lymph. Kidney Int (1984) 0.92
Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension (1992) 0.91
Angiotensin II exerts differential actions on renal nerve activity and heart rate. Hypertension (1994) 0.91
Coexistence of renin and angiotensin II in epitheloid cell secretory granules of rat kidney. Histochemistry (1984) 0.90
The renin-angiotensin system and long-term regulation of arterial pressure. J Hypertens (1986) 0.88
Close physical linkage of the murine Ren-1 and Ren-2 loci. Nucleic Acids Res (1988) 0.88
The renin-angiotensin system: renal actions and blood pressure regulation. Compr Ther (1991) 0.87
Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Kidney Int Suppl (1993) 0.86
Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc (1986) 0.86
Modulation of mouse renin gene expression by dietary sodium chloride intake in one-gene, two-gene and transgenic animals. J Hypertens (1989) 0.85
Unique specificity of mouse angiotensinogen to homologous renin. Proc Soc Exp Biol Med (1966) 0.85
Expression of the human renin gene in transgenic mice throughout ontogeny. Pediatr Nephrol (1993) 0.83
Brain and liver angiotensinogen messenger RNA in genetic hypertensive and normotensive rats. Hypertension (1991) 0.83
Renin secretion at the individual nephron level. Pflugers Arch (1975) 0.83
Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits. Endocrinology (1990) 0.82
Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ Res (1990) 0.82
Physical characterization of genetic rearrangements at the mouse renin loci. Genetics (1990) 0.81
Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressure-independent mechanism. Hypertension (1995) 0.81
Effect of angiotensin II on baroreceptor reflex control of heart rate in conscious baboons. Hypertension (1987) 0.81
Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. J Clin Invest (1993) 0.80
Plasma angiotensin in binephrectomised mice. Clin Exp Hypertens (1995) 0.79
Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat. J Hypertens (1989) 0.79
Tissue renin-angiotensin systems in renal hypertension. Hypertension (1992) 0.79
Interaction between angiotensin II and the baroreceptor reflex in the control of adrenocorticotropic hormone secretion and heart rate in conscious dogs. Circ Res (1986) 0.79
Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species-specific kinetics of the renin-angiotensin system. Arzneimittelforschung (1993) 0.77
Renal and extra-renal levels of renin mRNA in experimental hypertension. Clin Sci (Lond) (1991) 0.77
The amino-acid residues on the C-terminal side of the cleavage site of angiotensinogen influence the species specificity of reaction with renin. Biochim Biophys Acta (1988) 0.77
Differential expression of the murine and rat renin genes in peripheral subcutaneous tissue. Biochem Biophys Res Commun (1990) 0.77
Role of endogenous ANG II on resetting arterial baroreflex during development. Am J Physiol (1994) 0.76
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol (1988) 3.60
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
Natural mutation rates in the house mouse: plan of study and preliminary estimates. Mutat Res (1965) 2.68
Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol (1992) 2.51
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12
Marked hypocalcemia and ventricular fibrillation in two pediatric patients exposed to a fluoride-containing wheel cleaner. Ann Emerg Med (1996) 2.11
An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy. J Pediatr (1967) 1.92
Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol (1994) 1.91
Endopeptidase Clp: ATP-dependent Clp protease from Escherichia coli. Methods Enzymol (1994) 1.89
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Genetics of Duchenne muscular dystrophy. Annu Rev Genet (1988) 1.82
Spontaneous mutations and mutation rates in the house mouse. Genetics (1967) 1.80
The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem (1997) 1.78
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res (1998) 1.73
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem (2001) 1.72
Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum Genet (1984) 1.64
Two new proteases in the MHC class I processing pathway. Nat Immunol (2000) 1.63
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics (1999) 1.60
Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest (2000) 1.59
Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol (1998) 1.57
Aerobic performance of female marathon and male ultramarathon athletes. Eur J Appl Physiol Occup Physiol (1979) 1.53
Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr (1998) 1.53
Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res (2001) 1.50
Partial gene duplication in Duchenne and Becker muscular dystrophies. J Med Genet (1988) 1.50
Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens (1999) 1.42
Genetics of childhood spinal muscular atrophy. J Med Genet (1971) 1.39
Carbon monoxide mass exposure in a pediatric population. Acad Emerg Med (1998) 1.39
Differential requirement for SLP-76 domains in T cell development and function. Immunity (2001) 1.36
Endocardial fibroelastosis: family studies with special reference to counseling. J Pediatr (1971) 1.35
Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest (1996) 1.34
Molecular properties of ClpAP protease of Escherichia coli: ATP-dependent association of ClpA and clpP. Biochemistry (1998) 1.34
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29
Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo. J Biol Chem (1999) 1.28
Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem (2000) 1.25
Natural mutation rates in the house mouse. Estimates for five specific loci and dominant mutations. Mutat Res (1971) 1.25
Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem (1996) 1.22
Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res (2001) 1.22
Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem (1994) 1.22
Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Infect Dis J (1997) 1.22
Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol (2001) 1.19
Skeletal muscle metabolic and ionic adaptations during intense exercise following sprint training in humans. J Appl Physiol (1985) (2000) 1.19
Secondary sex ratio in mice. J Hered (1969) 1.17
Intramyocellular triacylglycerol in prolonged cycling with high- and low-carbohydrate availability. J Appl Physiol (1985) (2002) 1.16
Effect of training on eccentric exercise-induced muscle damage. J Appl Physiol (1985) (1993) 1.13
Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol (1999) 1.12
Spectinomycin resistance due to a mutation in an rRNA operon of Escherichia coli. J Bacteriol (1983) 1.11
Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics (2000) 1.11
Intelligence and the gene for Duchenne muscular dystrophy. Arch Dis Child (1969) 1.10
Mackinder's hereditary brachydactyly: phenotypic, radiological, dermatoglyphic and genetic observations in an Ontario family. Ann Hum Genet (1973) 1.10
Heritability of blood pressure in mice. J Hered (1966) 1.10
Sarcoplasmic reticulum function and muscle contractile character following fatiguing exercise in humans. J Physiol (2001) 1.09
Highly regulated cell type-restricted expression of human renin in mice containing 140- or 160-kilobase pair P1 phage artificial chromosome transgenes. J Biol Chem (1999) 1.09
Identification of cis elements in the cardiac troponin T gene conferring specific expression in cardiac muscle of transgenic mice. Circ Res (2000) 1.08
Genetic aspects of immotile cilia syndrome. Am J Med Genet (1986) 1.07
Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press (1999) 1.07
Analysis of effects of W and f genic substitutions on fetal mouse hematology. Genetics (1968) 1.06
Appropriate tissue- and cell-specific expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination. J Biol Chem (2000) 1.05
Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle. J Biol Chem (2000) 1.04
Developmental aspects of the renal response to hypoxemia in the lamb fetus. Circ Res (1981) 1.04
Familial atrial septal defect of the primum type: a report of four cases in one sibship. Can Med Assoc J (1968) 1.03
The influence of menstrual cycle phase on skeletal muscle contractile characteristics in humans. J Physiol (2001) 1.02
Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure. Am J Physiol Heart Circ Physiol (2010) 1.01
Genetic control of blood pressure in mice. Genetics (1967) 1.01
Selection for blood pressure levels in mice. Genetics (1974) 0.99
Analysis of erythroid homeostatic mechanisms in normal and genetically anaemic mice. Br J Haematol (1966) 0.99
Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem (1997) 0.99
Genetic counseling in clinical pediatrics. What to do with inquiries about heritable disorders. Clin Pediatr (Phila) (1967) 0.98
Consumption of electrolytes and quinine by mouse strains with different blood pressures. Physiol Behav (1998) 0.98
The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res (1999) 0.98
Relationships among age-associated strength changes and physical activity level, limb dominance, and muscle group in women. J Gerontol A Biol Sci Med Sci (2000) 0.97
NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension (2001) 0.97
Expression of murine renin genes during fetal development. Mol Endocrinol (1990) 0.97
Renal and adrenal responses to converting-enzyme inhibition in fetal and newborn life. Am J Physiol (1983) 0.97
Genome scan for blood pressure loci in mice. Hypertension (1999) 0.97
Vectors for high-level expression of cDNAs controlled by tissue-specific promoters in transgenic mice. Biotechniques (2001) 0.96
Effect of antenatal glucocorticoids on sympathetic nerve activity at birth in preterm sheep. Am J Physiol (1998) 0.95
Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol (2001) 0.95
Renin-angiotensin system in genetically hypertensive mice. Jpn Circ J (1984) 0.95
Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Can Med Assoc J (1976) 0.95
Species-specific differences in positive and negative regulatory elements in the renin gene enhancer. Circ Res (1999) 0.94
Specific cellular defects in patients with Fanconi anemia. J Cell Physiol (1979) 0.94
Physiological responses to prolonged exercise in ultramarathon athletes. J Appl Physiol (1985) (1986) 0.93
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke (2000) 0.93
Dermatophyphics in childhood leukemia. Can Med Assoc J (1971) 0.93
Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy. Am J Med Genet (1983) 0.93
Human skeletal sarcoplasmic reticulum Ca2+ uptake and muscle function with aging and strength training. J Appl Physiol (1985) (1999) 0.92
Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle Nerve (1979) 0.92
Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy. J Med Genet (1986) 0.92
Effect of cortisol on gene expression of the renin-angiotensin system in fetal sheep. Pediatr Res (1995) 0.92
Conserved enhancer elements in human and mouse renin genes have different transcriptional effects in As4.1 cells. Circ Res (1997) 0.92
Comparison of the adrenal and renal responses to angiotensin II fetal lambs and adult sheep. Circ Res (1982) 0.91
Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect (2014) 0.91
Allele-specific expression of the murine Ren-1 genes. J Biol Chem (1989) 0.91